Boehringer Ingelheim Animal Health
GPTKB entity
Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Merial
|
| gptkbp:CEO |
gptkb:Jean_Scheftsik_de_Szolnok
|
| gptkbp:focus |
companion animals
livestock animals |
| gptkbp:foundedYear |
2017
|
| gptkbp:headquartersLocation |
gptkb:Duluth,_Georgia,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Boehringer Ingelheim Animal Health
|
| gptkbp:industry |
animal health
|
| gptkbp:market |
global
|
| gptkbp:notableProduct |
gptkb:Metacam
gptkb:Frontline gptkb:Heartgard gptkb:Ingelvac_CircoFLEX gptkb:Ingelvac_PRRS_MLV gptkb:NexGard gptkb:Previcox |
| gptkbp:numberOfEmployees |
over 10,000
|
| gptkbp:parentCompany |
gptkb:Boehringer_Ingelheim
|
| gptkbp:products |
veterinary vaccines
parasiticides pharmaceuticals for livestock pharmaceuticals for pets |
| gptkbp:rank |
second largest animal health business worldwide (as of 2022)
|
| gptkbp:revenue |
€4.6 billion (2022)
|
| gptkbp:website |
https://www.boehringer-ingelheim.com/animal-health
|
| gptkbp:bfsParent |
gptkb:Boehringer_Ingelheim
|
| gptkbp:bfsLayer |
6
|